NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 9, 2016--
Lantheus
Holdings, Inc. (the “Company”) (NASDAQ:LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), today announced that Mary Anne Heino,
President and Chief Executive Officer, and Jack Crowley, Interim Chief
Financial Officer, will participate in an analyst-led fireside chat at
the RBC Capital Markets’ Global Healthcare Conference on Tuesday,
February 23, 2016, at 4:05 p.m. ET in New York.
To access a live webcast of the presentation, please visit the Company’s
website at www.lantheus.com.
A replay of the webcast will be available on the Company’s website for
30 days following the live presentation.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical
Imaging, Inc. (“LMI”), which is a global leader in developing,
manufacturing, selling and distributing innovative diagnostic imaging
agents and products. LMI provides a broad portfolio of products, which
are primarily used for the diagnosis of cardiovascular diseases. LMI’s
key products include the echocardiography contrast agent DEFINITY®
Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico, Canada and Australia. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160209006817/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
